Apelqvist J - Search Results

1

The global burden of diabetic foot disease.

Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. Boulton AJ, et al. Among authors: apelqvist j. Lancet. 2005 Nov 12;366(9498):1719-24. doi: 10.1016/S0140-6736(05)67698-2. Lancet. 2005. PMID: 16291066 Review.

2

Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting.

Apelqvist J, Ragnarson-Tennvall G, Larsson J, Persson U. Apelqvist J, et al. Foot Ankle Int. 1995 Jul;16(7):388-94. doi: 10.1177/107110079501600702. Foot Ankle Int. 1995. PMID: 7550950

3

Topical treatment of diabetic foot ulcers: an economic analysis of treatment alternatives and strategies.

Apelqvist J, Ragnarson-Tennvall G, Larsson J. Apelqvist J, et al. Diabet Med. 1995 Feb;12(2):123-8. doi: 10.1111/j.1464-5491.1995.tb00442.x. Diabet Med. 1995. PMID: 7743758

4

Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation.

Apelqvist J, Ragnarson-Tennvall G, Persson U, Larsson J. Apelqvist J, et al. J Intern Med. 1994 May;235(5):463-71. doi: 10.1111/j.1365-2796.1994.tb01104.x. J Intern Med. 1994. PMID: 8182403

5

Cavity foot ulcers in diabetic patients: a comparative study of cadexomer iodine ointment and standard treatment. An economic analysis alongside a clinical trial.

Apelqvist J, Ragnarson Tennvall G. Apelqvist J, et al. Acta Derm Venereol. 1996 May;76(3):231-5. doi: 10.2340/0001555576231235. Acta Derm Venereol. 1996. PMID: 8800307 Free article. Clinical Trial.

6

Cost-effective management of diabetic foot ulcers. A review.

Ragnarson-Tennvall G, Apelqvist J. Ragnarson-Tennvall G, et al. Among authors: apelqvist j. Pharmacoeconomics. 1997 Jul;12(1):42-53. doi: 10.2165/00019053-199712010-00005. Pharmacoeconomics. 1997. PMID: 10173073 Review.

7

Health-related quality of life in patients with diabetes mellitus and foot ulcers.

Ragnarson Tennvall G, Apelqvist J. Ragnarson Tennvall G, et al. Among authors: apelqvist j. J Diabetes Complications. 2000 Sep-Oct;14(5):235-41. doi: 10.1016/s1056-8727(00)00133-1. J Diabetes Complications. 2000. PMID: 11113684

8

Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations.

Ragnarson Tennvall G, Apelqvist J. Ragnarson Tennvall G, et al. Among authors: apelqvist j. Diabetologia. 2001 Nov;44(11):2077-87. doi: 10.1007/s001250100013. Diabetologia. 2001. PMID: 11719840

9

Health-economic consequences of diabetic foot lesions.

Ragnarson Tennvall G, Apelqvist J. Ragnarson Tennvall G, et al. Among authors: apelqvist j. Clin Infect Dis. 2004 Aug 1;39 Suppl 2:S132-9. doi: 10.1086/383275. Clin Infect Dis. 2004. PMID: 15306992

10

High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study.

Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, Van Acker K, van Baal J, van Merode F, Schaper N. Prompers L, et al. Among authors: apelqvist j. Diabetologia. 2007 Jan;50(1):18-25. doi: 10.1007/s00125-006-0491-1. Epub 2006 Nov 9. Diabetologia. 2007. PMID: 17093942

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page